Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytosorbents Corp (NASDAQ:CTSO)

5.20
Delayed Data
As of 3:21pm ET
 +0.35 / +7.22%
Today’s Change
3.11
Today|||52-Week Range
7.40
-6.64%
Year-to-Date
No recent news for Cytosorbents Corp.

Today’s Trading

Previous close4.85
Today’s open5.00
Day’s range4.97 - 5.35
Volume75,897
Average volume (3 months)80,991
Market cap$123.5M
Dividend yield--
Data as of 3:21pm ET, 12/07/2016

Growth & Valuation

Earnings growth (last year)+74.42%
Earnings growth (this year)-18.94%
Earnings growth (next 5 years)--
Revenue growth (last year)+16.22%
P/E ratioNM
Price/Sales28.93
Price/Book15.00

Competitors

 Today’s
change
Today’s
% change
LFVNLifeVantage Corp+0.50+6.43%
CDXCChromadex Corp-0.04-1.67%
CDTXCidara Therapeutics ...-0.20-1.84%
MTPMidatech Pharma PLC-0.24-8.28%
Data as of 3:31pm ET, 12/07/2016

Financials

Next reporting dateApril 4, 2017
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$4.8M
Annual profit (last year)-$8.1M
Net profit margin-169.71%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Phillip P. Chan
Chief Operating Officer
Vincent Capponi
Corporate headquarters
Monmouth Junction, New Jersey

Forecasts


Search for Jobs